Market activity and potential of generic and innovative drugs in Russia and Ukraine 2011

01-Mar-2011

I like this.

Be Sociable, Share!
-->

By







The report “Generic and innovative drugs market in Russia and Ukraine 2011” provides a comprehensive analysis of the generic and innovative drug segments in Russia and Ukraine,  with forecasts for 2011-2013, prepared by a team of pharmaceutical market analysts as well as PMR’s economy experts. These are supplemented with details of factors influencing different segments, especially reimbursement and pricing policies as well as government attitudes towards foreign and domestic pharmaceutical companies. Country policy descriptions in the area of counterfeit medicines as well as profiles of the largest generic and innovative drug manufacturers in Russia and Ukraine are also included in this publication.

Today’s economy requires businesses to keep close tabs on market activity in order to make sound decisions and maximise profits. If you are looking for the very latest and most viable data and analysis on the generic and innovative drugs market in Russia and Ukraine, you should read the latest PMR report “Generic and innovative drugs market in Russia and Ukraine 2011, Comparative analysis, reimbursement policies and development forecasts for 2011-2013”.

The first report of its kind to target Russia and Ukraine as two separate within the CEE region, it provides a comparative study of the two markets, analysing the effects of the economic crisis on the generic and innovative markets in Russia and Ukraine. The report includes the latest data on the value of the generic drug and innovative markets in both countries in 2007-2013 and their market share. Pricing policy is considered in terms of regulations regarding prices of non-reimbursed and reimbursed medicines in Russia and Ukraine, VAT rates and average and official mark-ups for medicines. An analysis of reimbursement policy is provided, including latest and future changes to reimbursement lists. The best selling generic and innovative medicines and the largest drug manufacturers in Russia and Ukraine are profiled.

“Generic and innovative drugs market in Russia and Ukraine 2011” combines valuable business intelligence from a variety of trusted sources into one clear, concise document – ready for delivery to you in a convenient electronic format.

Be Sociable, Share!
Tags: , , , ,

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

Subscribe without commenting









Loading...
Join Oxstones Investment Club's Daily Newsletter